Skip to Main Content

Paper Details

Anti-PF4 antibodies associated with disease severity in COVID-19.
Proc Natl Acad Sci U S A
12
2022
Anti-PF4 antibodies, Anti-PF4 antibody, COVID-, COVID-19, IgA, IgG, IgM, PF4, acute respiratory disease, anti-PF4 antibodies, immunoglobulin (Ig), microvascular thrombosis, patients, platelet, platelet factor 4, thrombocytopenia
Author NameAffiliation
Scott L ZegerJohns Hopkins Bloomberg School of Public Health
Daniel S ChertowNational Institute of Allergy and Infectious Diseases
Daniel S ChertowClinical Center, National Institute of Allergy and Infectious Diseases
Richard E RothmanJohns Hopkins University School of Medicine
  • 1 - 4

Datasets

Release 1.2